Omixon to Launch OmniType – Join Our Early Access Program!

21/10/2019

Omixon is gearing up to launch a Multiplex HLA typing product for use on Illumina sequencing platforms. This new product line – OmniType – is expected to be a best-in-class product featuring locus multiplexing and short library preparation. The requirements for its development came both from you in the HLA...

Interview with Gergely Tölgyesi, Molecular Biologist at Omixon

30/09/2019

The following interview is part of the Omixon interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers at Omixon. This time Gergely Tölgyesi, Technical Lead of Assay R&D answers questions related to his professional background, history of joining the Omixon team and shares secrets about...

Welcome to the Team, Elmar!

30/09/2019

We are proud to announce and welcome Elmar Schilling, who has recently joined our company as the Chief Technology Officer of Omixon. Elmar was born and raised in Bavaria, the southern part of Germany. He graduated in Molecular Biology and completed his PhD studies in the field of Epigenetics at Regensburg University ...

Omixon at ASHI 2019 – HLA Typing Applications Beyond Transplantation

27/09/2019

Thank you everyone for another exciting and eventful ASHI Meeting! The (big!) Omixon Team – Efi, Renata, Nora, Kriszta, Pete, Dan, Nandi, Joe, Richie, Gustavo, Libor and Attila – went on a trip to Pittsburgh to explore the city’s best meatballs, wonderful bridges and skyline. The conference was held at...

ASHI, September 23-27, 2019

06/09/2019

We are happy to invite everyone to our ABHI accredited events at ASHI 2019 in Pittsburgh, PA! This is what you can expect from us: User Group Meeting – Monday, September 23, 2019 at 12:00pm- 4:30pm Venue: Room 333, David L. Lawrence Convention Center, Level 3 Join us...